ROBERT BRANSFIELD: Open Payments
NPI 1467449769 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112,559 in 215 payments from 15 companies in 2025. Trend: 2023 $79,592 · 2024 $113,966 · 2025 $112,559
Speaker / faculty: $89,685Travel & lodging: $12,741Food & beverage: $5,483Consulting: $4,590Education: $61
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 115 | $110,753 |
| JAZZ PHARMACEUTICALS INC. | 13 | $346 |
| Teva Pharmaceuticals USA, Inc. | 12 | $273 |
| Bausch Health US, LLC | 17 | $226 |
| Alkermes, Inc. | 11 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $173 |
| Axsome Therapeutics, Inc. | 5 | $170 |
| ABBVIE INC. | 11 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $96 |
| Almatica Pharma LLC | 5 | $78 |
Products named: CAPLYTA, XYWAV, AUSTEDO XR, TRINTELLIX, ARISTADA, WELLBUTRIN, Sunosi, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
